A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting substances of uncertain source.
Some experts said the demand for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Material Removal
According to the social media company, the platform has removed violative content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or administering at home.
After minutes of joining one group, a seller posted contact information, where most purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Information and Costs
Within these groups, messages show dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.
